| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.61▲ | 7.66▼ | 7.71▼ | 7.71▼ | 7.65▼ |
| MA10 | 7.61▲ | 7.71▼ | 7.70▼ | 7.78▼ | 7.42▲ |
| MA20 | 7.62▼ | 7.69▼ | 7.66▼ | 7.69▼ | 7.33▲ |
| MA50 | 7.70▼ | 7.66▼ | 7.78▼ | 7.50▲ | 13.70▼ |
| MA100 | 7.71▼ | 7.80▼ | 7.80▼ | 7.43▲ | 22.95▼ |
| MA200 | 7.67▼ | 7.80▼ | 7.42▲ | 11.54▼ | 32.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.013▼ | 0.007▲ | -0.025▼ | 0.572▲ |
| RSI | 45.788▼ | 43.835▼ | 44.130▼ | 50.029▲ | 39.355▼ |
| STOCH | 43.985 | 29.679 | 57.229 | 33.345 | 67.414 |
| WILL %R | -29.630 | -73.239 | -73.239 | -80.810▼ | -30.820 |
| CCI | 10.239 | -136.311▼ | -69.309 | -90.284 | 33.746 |
| ▼ MACD | $ARVN MACD(12,26,9) Crossed Below Signal Line | Set Alert |
|
Wednesday, September 17, 2025 01:46 PM
Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures expected to realize total annual savings of ...
|
|
Tuesday, September 09, 2025 07:12 AM
Arvinas, Inc. ( NASDAQ: ARVN) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 12:45 PM EDT ...
|
|
Thursday, August 28, 2025 05:00 PM
NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 7.675 | 7.875 | 7.52 | 7.615 | 1,060,971 |
| 16/09/25 | 7.74 | 7.74 | 7.52 | 7.64 | 1,507,588 |
| 15/09/25 | 7.80 | 7.89 | 7.555 | 7.74 | 949,198 |
| 12/09/25 | 7.82 | 7.855 | 7.56 | 7.74 | 1,200,903 |
| 11/09/25 | 7.81 | 8.08 | 7.70 | 7.81 | 1,841,991 |
| 10/09/25 | 7.96 | 8.095 | 7.79 | 7.83 | 1,318,757 |
| 09/09/25 | 7.90 | 8.105 | 7.81 | 8.00 | 1,206,346 |
| 08/09/25 | 7.81 | 8.2256 | 7.58 | 7.94 | 2,029,423 |
| 05/09/25 | 7.65 | 8.20 | 7.63 | 7.83 | 1,891,598 |
| 04/09/25 | 7.87 | 7.87 | 7.47 | 7.61 | 1,199,615 |
|
|
||||
|
|
||||
|
|